COVID-19

Tocilizumab   

Questions discussed in this category


Current guidelines do not support its use, but the EMPACTA trial suggests it may be effective in a subpopulation of patients.


Papers discussed in this category


N Engl J Med, 2020 Dec 10

N Engl J Med, 2020 Dec 17